RPT-Baseball-MLB, players agree to expand drug testing

Jan 10 (Reuters) - Major League Baseball and the players' union have agreed to expand their drug program to include random in-season blood testing for human growth hormone and a new test for testosterone, they said on Thursday.
The testing will start this season.
MLB has been conducting random blood testing for the detection of HGH among minor league players since July 2010.
Starting this season, the World Anti-Doping Agency (WADA)-accredited Montreal laboratory will establish a program in which a player's baseline testosterone/epitestosterone (T/E) ratio and other data will be maintained in order to enhance its ability to detect use of testosterone and other prohibited substances.
Read More..

UPDATE 1-Baseball-MLB, players agree to expand drug testing

* HGH and testosterone testing to be used this season
* WADA-accredited lab hails toughness of new MLB testing (Adds details, quotes)
Jan 10 (Reuters) - Major League Baseball and the players' union have agreed to expand their drug program to include random in-season blood testing for human growth hormone and a new test for testosterone, they said on Thursday.
The advanced testing will start this season, in what will be the sternest doping program in major North American professional sports.
"This agreement addresses critical drug issues and symbolizes Major League Baseball's continued vigilance against synthetic human growth hormone, testosterone and other performance-enhancing substances," MLB commissioner Bud Selig said in a statement.
The new steps moved baseball well ahead of the National Football League, which does not test for HGH or testosterone.
"Players want a program that is tough, scientifically accurate, backed by the latest proven scientific methods, and fair," said Michael Weiner, MLB Players' Association executive director in a statement.
"I believe these changes firmly support the players' desires while protecting their legal rights."
The announcement came one day after the players' union criticized results of the balloting for the Baseball Hall of Fame, in which no one received enough votes for enshrinement in what appeared to be a referendum on widespread doping during what has become known as the game's 'Steroids Era'.
All-time home run king Barry Bonds and seven-time Cy Young winning pitcher Roger Clemens, have resumes that would have ordinarily made them certain Hall of Famers.
But both players have been linked to performance enhancing drugs and punished by voters, receiving about half the ballots votes required for election.
Major League Baseball, striving to remove the taint of doping, was the first major sport in the United States to test for HGH in an agreement with the union in November 2011.
MLB has been conducting random blood testing for the detection of HGH among minor league players since July 2010 and had previously been testing major leaguers during spring training and off-season.
To detect testosterone use, the World Anti-Doping Agency (WADA)-accredited Montreal laboratory will establish a program in which a player's baseline testosterone/epitestosterone (T/E) ratio and other data will be maintained in order to enhance its ability to detect use of the drug and other banned substances.
Christiane Ayotte, the Director of the Montreal Laboratory, praised the steps baseball has taken.
"The addition of random blood testing and a longitudinal profiling program makes baseball's program second to none in detecting and deterring the use of synthetic HGH and testosterone," she said in a statement.
Doping in baseball has not disappeared.
In the last year, Melky Cabrera of the San Francisco Giants, who was leading the league in batting average, and Oakland A's pitcher Bartolo Colon tested positive for testosterone and were suspended.
"I am proud that our system allows us to adapt to the many evolving issues associated with the science and technology of drug testing," Selig said. "We will continue to do everything we can to maintain a leadership stature in anti-doping efforts in the years ahead."
Read More..

MLB to expand blood testing for HGH

PARADISE VALLEY, Ariz. (AP) — Major League Baseball will test for human growth hormone throughout the regular season and increase efforts to detect abnormal levels of testosterone, a decision the NFL used to pressure its players.
Baseball players were subject to blood testing for HGH during spring training last year, and Thursday's agreement between management and the Major League Baseball Players Association expands that throughout the season. Those are in addition to urine tests for other performance-enhancing drugs.
Under the changes to baseball's drug agreement, the World Anti-Doping Agency laboratory in Laval, Quebec, will keep records of each player, including his baseline ratio of testosterone to epitestosterone, and will conduct Carbon Isotope Ratio Mass Spectrometry (IRMS) tests of any urine specimens that "vary materially."
"This is a proud and a great day for baseball," commissioner Bud Selig said following two days of owners' meetings. "We'll continue to be a leader in this field and do what we have to do."
The announcement came one day after steroid-tainted stars Barry Bonds, Roger Clemens and Sammy Sosa failed to gain election to the Hall of Fame in their first year of eligibility.
Commenting on the timing, Selig noted the drug program changes had long been in the works "but it wasn't too bad, was it?"
Selig reflected on how far baseball had come on performance enhancing drug issues.
"This is remarkable when you think of where we were 10, 12, 15 years ago and where we are today," he said. "Nobody could have dreamed it."
Baseball began random drug testing in 2003, testing with penalties the following year and suspensions for first offenders in 2005. Initial penalties were lengthened from 10 days to 50 games in 2006, when illegal amphetamines were banned. The number of tests has gradually increased over the past decade.
Selig called the latest change a "yet another indication how far this sport has come."
Rob Manfred, baseball's executive vice president for economics and league affairs, said each player will be tested at least once.
"Players want a program that is tough, scientifically accurate, backed by the latest proven scientific methods, and fair," union head Michael Weiner said in a statement. "I believe these changes firmly support the players' desires while protecting their legal rights."
Selig praised the cooperation of the players association, once a staunch opponent of drug testing, in agreeing to the expansion.
"Michael Weiner and the union deserve credit," Selig said. "Way back when they were having a lot of problems I didn't give them credit, but they do."
Christiane Ayotte, director of the Canadian laboratory, said that the addition of random blood testing and a "longitudinal profiling program makes baseball's program second to none in detecting and deterring the use of synthetic HGH and testosterone."
She said the program compares favorably with any program conducted by WADA.
HGH testing remains a contentious issue in the National Football League. At a hearing last month, U.S. Rep. Elijah Cummings, the ranking Democrat on the House Oversight and Government Reform Committee, accused the NFL players' union of trying to back out of HGH testing.
"Other professional sports leagues, including the National Football League, must also implement their own robust testing regimes," Cummings and committee chairman Darrel Issa said in a statement Thursday. "Major League Baseball's announcement increases the pressure on the NFL and its players to deliver on pledges to conduct HGH testing made in their collective bargaining agreement that was signed two years ago."
NFL spokesman Greg Aiello said Thursday "we hope the MLB players' union will inspire the NFLPA to stop its stalling tactics and fulfill its commitment to begin testing for HGH. If the NFLPA stands for player health and safety, it should follow the lead of the MLB players' union and end the delay."
NFLPA spokesman George Atallah says the union is not backing out of anything but was looking to resolve scientific issues surrounding the tests. HGH testing is part of the 10-year labor agreement reached in 2011 but protocols must be agreed to by both sides.
"If the league had held up their commitment to population study, we could have been first," Atallah said.
At the time of last month's congressional hearing, NFL senior vice president Adolpho Birch called the union's insistence on a population study to determine whether current HGH tests are appropriate a delay tactic that threatened that league's leadership in drug testing matters.
"Major League Baseball and the players' union have moved a long way from the inadequate policies that were in place when Congress first addressed ballplayers' use of steroids." said Henry Waxman, ranking Democrat on the House Energy and Commerce Committee.
NOTES: Owners approved the transfer of control of the Cleveland Indians to Paul Dolan, son of owner Larry Dolan. Paul Dolan is the team's chief executive officer.
Read More..

Amazon and Samsung are running away with the Android tablet market

Following the successful launch of Amazon’s Kindle Fire tablet, Android vendors saw a beacon of hope in a market that had been dominated by Apple’s (AAPL) iPad since 2010. The Android tablet space has since become flooded with hundreds of products from a wide-range of companies, but there are only two companies that matter.
[More from BGR: ‘Apple is done’ and Surface tablet is cool, according to teens]
According to data from app analytics and ad service Datalytics, Samsung (005930) and Amazon (AMZN) are starting to run away with the Android tablet market, Venture Beat reported.
[More from BGR: Is BlackBerry back? Strong early BlackBerry 10 demand could signal RIM comeback]
Ad impressions on the 7-inch Kindle Fire HD grew 322% from November to the end of December, while impressions on the Galaxy Tab 10.1 and Tab 7.7 increased a combined total of 150%. Google’s (GOOG) Nexus 7 and Barnes & Noble’s (BKS) Nook Tablet were the next closest with 70% and 62% growth in December, respectively.
The firm’s data also confirms Samsung’s dominant smartphone share, which saw a combined total of 214% growth in the past month.
The data also revealed that the iPhone 4S is still the most popular Apple smartphone with 40% of the market, compared to the iPhone 4′s 36% share and iPhone 5′s 18% share. On the iOS tablet side of things, the iPad mini is apparently selling a little slower than the iPad 4. The fourth-generation tablet had an 8% share of the iPad market, slightly higher than the mini’s 6% share.
Datalytics’ information comes from tens of thousands of apps installed on more than 60 million devices.
Read More..

Academy Launches Oscar App on Android, Amazon

LOS ANGELES (TheWrap.com) - The Academy launched its official Oscars app on Android and Amazon on Thursday, expanding its initiative to direct fans' attention from the television to the second screen.
The app, already available on the iPad and iPhone, was made available for free on the Google Play store and the Amazon app store, the Academy said. According to iTunes, the iPad app was updated earlier on Wednesday.
Developed by the Academy and Disney/ABC Television Group's digital media arm, the app allows users to see behind-the-scenes videos and stories with host Seth MacFarlane and search information about the nominees. It also features a "My Picks" ballot on which users can organize their dream-team of winners.
On Oscar night on February 24, the app will feature "Backstage Pass," a live telecast from more than a dozen cameras placed on the Red Carpet and throughout the Dolby Theatre - in the press room, the control room, backstage and elsewhere.
And a ticker on the app will notify when a users' favorite actor and actress arrives on stage.
"We're always looking for ways to bring fans closer to the show and this app provides a unique and fun way to do that," Josh Spector, the managing director of digital media and marketing for the Academy, said in a statement. "More fans than ever will be able to enjoy the full Oscar experience now that our app is available to Droid users.
Read More..

Report links drug agents to Secret Service prostitute scandal: NBC

WASHINGTON (Reuters) - Two drug enforcement agents "facilitated a sexual encounter" between a prostitute and a Secret Service agent before an international summit in Colombia last April, NBC News reported on Thursday, citing a Justice Department investigation.
The two Drug Enforcement Administration agents also admitted paying for the sexual services of a prostitute, and used their government-issued BlackBerry devices to arrange the encounters, NBC reported.
A summary of the Justice Department's findings said the agents tried to destroy incriminating information or initially lied to investigators about the incidents, according to the report.
But the summary concluded that the agents' actions did not warrant criminal prosecution, and said the U.S. Attorney's Office declined to start any legal proceedings, referring the case to the DEA for "action it determines to be appropriate."
The Justice Department's office of the inspector general had no comment on Thursday evening.
It was the latest turn in the Colombia prostitution scandal, in which a dozen Secret Service employees were accused of misconduct for bringing women, some of them prostitutes, to their hotel rooms in Cartagena, Colombia, before President Barack Obama's visit there in April.
The Department of Homeland Security found that their actions did not compromise the president's safety. At least seven of the employees have left the agency since the scandal broke.
Read More..

Canadian dollar overlooks U.S. results in rangebound trade

TORONTO (Reuters) - Canada's dollar ended slightly lower against its U.S. counterpart on Wednesday, shrugging off a modest rally in other riskier assets after Alcoa opened the U.S. earnings season with an optimistic outlook.
Global equities staged a modest recovery after two days of losses. Even with the encouraging Alcoa report, investors lacked a clear view of how U.S. corporations fared in the fourth-quarter and the Canadian currency was rangebound.
Adam Cole, global head of FX strategy at RBC Capital Markets in London, expected more reaction to U.S. earnings once they picked up steam.
"If that's where stocks take their direction then it's difficult to get away from that, being a fairly major barometer of pressure on CAD," he said.
There was caution a day ahead of European and British central bank policy meetings, as well as a Spanish auction that will test appetite for peripheral euro zone debt, and Chinese trade data.
On the home front, the next major event of interest is a speech on Thursday by Tiff Macklem, a senior Bank of Canada official widely tipped to replace the departing Governor Mark Carney.
"Investors are looking toward Tiff Macklem's speech to see if there are any hints of his policy takes, if they're any different from Carney's, which is highly unlikely I think," said John Curran, senior vice president at CanadianForex.
"If anything, the Canadian dollar is remaining in positive territory recently speaking due to last week's (jobs) numbers and expectations that frontrunner Macklem is going to be towing the line so to speak with previous BoC sentiment."
The Bank of Canada stands apart from other major central banks in that it avoided large bouts of quantitative easing and now insists the next move in interest rates is likely to be up.
The Canadian dollar ended the North American session at C$0.9877 versus the greenback, or $1.0125, slightly weaker than Tuesday's close at C$0.9867, or $1.0135. It traded in a tight 26-point range between C$0.9855-C$0.9881.
U.S. profits were expected to beat the previous quarter's lackluster results, but analyst estimates were down sharply from October. Quarterly earnings were expected to grow by 2.7 percent, according to Thomson Reuters data.
RBC noted near-term U.S. dollar resistance versus the Canadian dollar around C$0.9947 and support near C$0.9826.
Analysts noted that the looming U.S. debt ceiling talks also kept investors on the sidelines.
Still, the Canadian dollar was outperforming some other major currencies such as the yen, as renewed expectations of easier Bank of Japan monetary policy led some investors to sell the Japanese currency.
Canadian bond prices were also little changed across the curve. The two-year bond was off nearly 1 Canadian cent to yield 1.168 percent, while the benchmark 10-year bond was down 2 Canadian cents to yield 1.910 percent.
Read More..

Wall Street rises after Alcoa reports earnings

NEW YORK (Reuters) - Stocks rose on Wednesday, rebounding from two days of losses, as investors turned their focus to the first prominent results of the earnings season.
Stocks had retreated at the start of the week from the S&P 500's highest point in five years, hit last Friday, on worries about possible earnings weakness.
Shares of Alcoa Inc were down 0.5 percent to $9.08 after early gains, following the company's earnings release after the bell on Tuesday. The largest U.S. aluminum producer said it expects global demand for aluminum to grow in 2013.
Herbalife Ltd stock rose 4.2 percent to $39.95 in its most active day of trading in the company's history after hedge fund manager Dan Loeb took a large stake in the nutritional supplements seller. Prominent short-seller Bill Ackman had previously accused the company of being a "pyramid scheme," which Herbalife has denied.
Traders have been cautious as the current quarter shaped up like the previous one, with companies recently lowering expectations, said James Dailey, portfolio manager of Team Asset Strategy Fund in Harrisburg, Pennsylvania. Lower expectations leave room for companies to surprise investors even if their results are not particularly strong.
"The big question and focus is on revenue, and Alcoa had better-than-expected revenue," which calmed the market a little, Dailey said.
Overall, corporate profits were expected to beat the previous quarter's meager 0.1 percent rise. Both earnings and revenues in the fourth quarter are expected to have grown by 1.9 percent, according to Thomson Reuters data.
The Dow Jones industrial average <.dji> gained 61.66 points, or 0.46 percent, to 13,390.51. The Standard & Poor's 500 Index <.spx> rose 3.87 points, or 0.27 percent, to 1,461.02. The Nasdaq Composite Index <.ixic> gained 14.00 points, or 0.45 percent, to 3,105.81.
Facebook Inc shares rose above $30 for the first time since July 2012, trading up 5.3 percent at $30.59. Facebook, which has been tight-lipped about its plans after its botched IPO in May, invited the media to its headquarters next week.
Clearwire Corp shares jumped 7.2 percent to $3.13 after Dish Network bid $2.28 billion for the company, beating out a previous Sprint offer and setting the stage for a takeover battle for the wireless service provider that owns crucial mobile spectrum.
Apollo Group Inc slid after heavier early losses, a day after it reported lower student sign-ups for the third straight quarter and cut its operating profit outlook for 2013. Apollo's shares were last off 7.8 percent at $19.32.
Volume was below the 2012 average of 6.42 billion shares traded per day, as 6.10 billion were traded on the New York Stock Exchange, NYSE MKT and Nasdaq.
Advancing stocks outnumbered declining ones on the NYSE by 2,014 to 963, while on the Nasdaq advancers beat decliners 1,603 to 859.
Read More..

Asia stocks rise on positive start to US earnings

BANGKOK (AP) — A positive start to U.S. corporate earnings season helped boost Asian stock markets Thursday.
Major regional benchmarks rose on the heels of a handful of better-than-expected results that also lifted Wall Street.
Consumer products maker Helen of Troy, whose brands include Dr. Scholl's and Vidal Sassoon, reported a 15 percent profit increase. Electronic payments processor Global Payments said its fiscal second-quarter earnings rose nearly 15 percent, beating Wall Street expectations.
After markets closed Tuesday, Alcoa Inc. predicted rising demand for its aluminum this year and topped revenue expectations for the fourth quarter. Earlier in the day, agricultural products giant Monsanto said its profit tripled and raised its guidance for 2013.
Japan's Nikkei 225 index rose 0.9 percent to 10,677.74. Hong Kong's Hang Seng gained 1 percent to 23,439.46. South Korea's Kospi added 0.7 percent to 2,005.39 and Australia's S&P/ASX 200 advanced 0.4 percent to 4,725.80.
The European Central Bank will meet later Thursday to set monetary policy for the 17 countries that use the euro. It is expected to keep its benchmark interest rate unchanged at the record low of 0.75 percent even though the eurozone economy as a whole is back in recession. Investors are also awaiting the release in the U.S. of weekly jobless claims.
On Wall Street, the Dow Jones industrial average rose 0.5 percent to close at 13,390.51 on Wednesday. The Standard & Poor's 500 rose 0.3 percent to 1,461.02. The Nasdaq composite index rose 0.5 percent to 3,105.81.
Benchmark crude oil contract for February delivery was up 33 cents to $93.44 per barrel in electronic trading on the New York Mercantile Exchange. The contract fell 5 cents to close at $93.10 per barrel on the Nymex on Wednesday.
In currencies, the euro fell to $1.3047 from $1.3053 while the dollar rose to 88.05 yen from 87.75 yen.
Read More..

Golf-Goosen returns after "totally disintegrated" disc

Jan 8 (Reuters) - Twice U.S. Open winner Retief Goosen will play his first tournament for nearly five months at this week's Volvo Golf Champions in South Africa after having surgery on a "totally disintegrated" disc in his back.
The 43-year-old South African, who rated his health as "about five out of 10" at the WGC-Bridgestone Invitational in August in his penultimate event before an extensive break to repair his back, is itching to play tournament golf again.
"I'm very excited about the New Year," said Goosen who is making his comeback about six weeks ahead of schedule. "Obviously the last three years have been pretty bad.
"Last year I tried a bit of everything... injections, loads of physio, anything you could think of but nothing really helped. In the end we had no choice but to have the operation," he told the European Tour website (www.europeantour.com).
"It's been great. It's been almost five months now. I've been off painkillers and that cleans the system out a little bit. I started hitting balls, or half shots, about three weeks ago and I felt pretty good."
Goosen, who has 14 European Tour wins to his name but has not triumphed on the circuit since 2007, said he entered this week's event in Durban just before the deadline.
The 2001 and 2004 U.S. Open winner lost to compatriot Branden Grace in a playoff, which also featured Ernie Els, at the same event last year and said 2013 could be his season such is the unpredictability of golf.
Read More..